Literature DB >> 22050800

Fibrodysplasia ossificans progressiva: anesthetic management in complex orthopedic spine procedures.

Reza Gorji1, Fenghua Li, Robert Nastasi, Sarah Stuart.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare disorder of the connective tissue leading to progressive tissue ossification and immobilization. Soft-tissue trauma may exacerbate this condition, causing further ossification. Multisystem involvement includes restrictive lung disease, cervical ankylosis with limited mouth opening, and cardiac dysfunction. A 39-year-old woman with FOP presented with multiple orthopedic spine and femur fractures sustained from a fall. Anesthetic management was complicated by airway, pulmonary, and positioning challenges. Neuromonitoring allowed identification of spinal cord ischemia while avoiding a wake-up test. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22050800     DOI: 10.1016/j.jclinane.2010.11.004

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  3 in total

1.  General anesthesia in fibrodysplasia ossificans progressive: a case report and clinical review.

Authors:  Jin-Xing Liu; Rong Hu; Yu Sun; Hong Jiang
Journal:  Int J Clin Exp Med       Date:  2014-05-15

2.  General anesthesia for dental procedures in patients with fibrodysplasia ossificans progressiva: a review of 42 cases in 30 patients.

Authors:  Elaine Kilmartin; Zvi Grunwald; Frederick S Kaplan; Burton L Nussbaum
Journal:  Anesth Analg       Date:  2014-02       Impact factor: 5.108

3.  Surgical and Radiological Management of Complicated Uterine Leiomyoma Aided by 3D Models in a Patient with Fibrodysplasia Ossificans Progressiva.

Authors:  Michelle Ho; Beau Y Park; Norman G Rosenblum; Mona Al Mukaddam; Frederick S Kaplan; Victor Kucherov; Scott G Hubosky; Gregory Kane; Vishal Desai; Michael R Kramer; Bon S Ku; Eric S Schwenk; Jaime L Baratta; Deepti Harshavardhana; Zvi Grunwald
Journal:  Am J Case Rep       Date:  2021-06-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.